FDA approves lisocabtagene maraleucel (liso-cel or JCAR-017) a CAR-T cell therapy for relapsed or refractory large B-cell lymphoma
A fun and simple comic flip book that CAR-T from the point of view of a T-cell.
Related posts
CLL Society
Patients and providers fighting CLL together
Smart Patients Get Smart Care™
The Amazing Transformation of CAR-T A Comic Book Introduction to CAR-T
You are here:
